
COPENHAGEN, May 16 (Reuters) - Discussions between Novo Nordisk NOVOb.CO and the Novo Nordisk Foundation that controls the company regarding a CEO change have been ongoing for the past few weeks, the company's board Chair Helge Lund told Reuters on Friday.